Experts are excitedly examining retatrutide, a promising medication from Eli Lilly, as a possible advance in physique loss . Unlike many earlier approaches, retatrutide is a double -action receptor targeting simultaneously GLP-1 and GIP, substances that influence hunger and blood sugar balance. Ear